Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic reviewAnzola, L. K., Glaudemans, A. W. J. M., Dierckx, R. A. J. O., Martinez, F. A., Moreno, S. & Signore, A., Nov-2019, In : European Journal of Nuclear Medicine and Molecular Imaging. 46, 12, p. 2496-2513 18 p.
Research output: Contribution to journal › Article › Academic › peer-review
OBJECTIVE: To review the literature on the clinical application of radiolabeled somatostatin receptor scintigraphy (SRS) by SPECT and PET in adults with chronic inflammatory diseases.
RESEARCH DESIGN: Systematic review of published observational studies between 1993 and 2017.
DATA COLLECTION AND ANALYSIS: The Cochrane Central Register of Controlled Trials, MedLine, EMBASE, PubMed, Google Scholar, OVID, EBSCO, Scopus, and Web of Science were used to search for studies on the use of SRS in adults with chronic inflammatory diseases. A team of reviewers independently screened for eligible studies. Quality of evidence was assessed by QUADAS approach.
RESULTS: Eligible papers included 38 studies. Studied populations were heterogeneous, and patients were classified according to the diagnosed disease: endothelial inflammation, rheumatoid arthritis, cardiac allograft rejection, granulomatous diseases, small vessel vasculitis, idiopathic pulmonary fibrosis, sarcoidosis, and thyroid exophthalmopathy. Because of many quality differences between studies, it was not possible to pool data, and a narrative synthesis is reported.
CONCLUSION: Results highlight the value of SRS to detect active inflammation in several chronic inflammatory conditions, despite the bias related to the index test, showing lack of standardization of the scintigraphic technique and high variability of methods used to clinically evaluate inflammatory condition.
|Number of pages||18|
|Journal||European Journal of Nuclear Medicine and Molecular Imaging|
|Publication status||Published - Nov-2019|